Evidence map›Paper›PMID 32778663›Full record

ArticleScientific reports2020

Author Correction: Hybrid PET/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer's disease mouse model.

Georgia R Frost, Valerie Longo, Thomas Li, Lauren A Jonas, Martin Judenhofer, Simon Cherry, Jason Koutcher, Carl Lekaye, Pat Zanzonico, Yue-Ming Li

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Abnormal [Synapse (New York, N.Y.) · 2023
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Georgia R FrostChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Valerie LongoSmall Animal Imaging Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Thomas LiChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Lauren A JonasChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Martin JudenhoferDepartment of Biomedical Engineering, University of California, Davis, CA, 95616, USA.
Simon CherryDepartment of Biomedical Engineering, University of California, Davis, CA, 95616, USA.
Jason KoutcherDepartments of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Carl LekayeDepartments of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Pat ZanzonicoDepartments of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. zanzonip@mskcc.org.
Yue-Ming LiChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. liy2@mskcc.org.
Memorial Sloan Kettering Cancer Center · USUniversity of California, Davis · USCornell University · US

Funding

Regulation of y-secretase activity by modulatory proteinsR01AG061350 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI LI, YUEMING · 2019 to 2023
$4.3M
Mechanism and Synergy of gamma-Secretase ModulatorsR01NS096275 · NINDS · SLOAN-KETTERING INST CAN RESEARCH · PI LI, YUEMING · 2016 to 2020
$2.1M
NIA NIH HHS R01 AG061350NINDS NIH HHS R01 NS096275
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32778663
PMCPMC7417542
OpenAlexW3048667306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.